GM Watch
  • Main Menu
    • Home
    • News
      • Newsletter subscription
      • News Reviews
      • News Languages
        • Notícias em Português
        • Nieuws in het Nederlands
        • Nachrichten in Deutsch
      • Archive
    • Articles
      • GM Myth Makers
      • GM Reports
      • GM Quotes
      • GM Myths
      • Non-GM successes
      • GM Firms
        • Monsanto: a history
        • Monsanto: resources
        • Bayer: a history
        • Bayer: resources
    • Videos
      • Latest Videos
      • Must see videos
      • Agriculture videos
      • Labeling videos
      • Animals videos
      • Corporations videos
      • Corporate takeover videos
      • Contamination videos
      • Latin America videos
      • India videos
      • Asia videos
      • Food safety videos
      • Songs videos
      • Protests videos
      • Biofuel myths videos
      • Index of GM crops and foods
      • Index of speakers
      • Health Effects
    • Contact
    • About
    • Donations
News and comment on genetically modified foods and their associated pesticides    
  • News
    • Newsletter subscription
    • News Reviews
    • News Languages
      • Notícias em Português
      • Nieuws in het Nederlands
      • Nachrichten in Deutsch
    • Archive
      • 2022 articles
  • Articles
    • GM Myth Makers
    • GM Reports
    • GM Quotes
    • GM Myths
    • Non-GM successes
    • GM Firms
      • Monsanto: a history
      • Monsanto: resources
      • Bayer: a history
      • Bayer: resources
  • Donations
  • Videos
    • Index of speakers
    • Glyphosate Videos
    • Latest Videos
    • Must see videos
    • Health Effects
    • Agriculture videos
    • Labeling videos
    • Animals videos
    • Corporations videos
    • Corporate takeover videos
    • Contamination videos
    • Latin America videos
    • India videos
    • Asia videos
    • Food safety videos
    • Songs videos
    • Protests videos
    • Biofuel myths videos
    • Index of GM crops and foods
  • Contact
  • About

GMWatch Facebook cornfield banner

INTRODUCTION TO GM

GMO Myths and Facts front page.jpg

SCIENCE SUPPORTS REGULATION OF GENE EDITING

Plant tissue cultures

GENE EDITING: UNEXPECTED OUTCOMES AND RISKS

Damaged DNA on fire

GENE EDITING MYTHS AND REALITY

A guide through the smokescreen

Gene Editing Myths and Reality

ON-TARGET EFFECTS OF GENE EDITING

Damaged DNA

Growers oppose drugs made of flax

  • Print
  • Email
Details
Published: 15 June 2005
Twitter

EXCERPT: AmeriFlax said it worries about genetically engineered grain entering the food chain, a prospect it calls "unacceptable."
------

Growers oppose drugs made of flax
Associated Press
http://www.billingsgazette.com/index.php?id=1&display=rednews/2005/06/15/build/state/50-flax-drugs.inc

GRAND FORKS, N.D. - A North Dakota flax marketing group is opposing a plant-based pharmaceutical company planned here, citing potential contamination of traditional flax fields by genetically modified crops.

"Are we going to risk our new and emerging markets for the flax on something that hasn't even been licensed yet?" said Ernie Hoffert, a Carrington farmer and secretary-treasurer of AmeriFlax, a branch of the North Dakota Oilseed Council. "This is absurd."

Agragen, a company started by Cincinnati entrepreneur Sam Huttenbauer Jr., has leased space in the University of North Dakota technology park. The company plans to use North Dakota-grown flax in medicines such as albumin, which would be used in blood transfusions for trauma patients.

Huttenbauer said the market potential for plant-made pharmaceuticals would boost the flax industry in North Dakota, which grows more than 90 percent of the U.S. crop.

AmeriFlax said it worries about genetically engineered grain entering the food chain, a prospect it calls "unacceptable."

AmeriFlax last week met with about 30 people involved in the North Dakota flax industry, seeking help in drafting a statement that would strengthen its opposition to production of pharmaceuticals made from flax.

"I do not want to make this specific to Agragen," Hoffert said.

A statement from Huttenbauer that was handed out at the meeting pledged not to move ahead with transgenic flax in North Dakota until regulatory agencies and AmeriFlax agreed that all necessary safeguards had been met. Agragen also is seeking the full support of AmeriFlax, and help from the group and the state in finding development money.

No plant-made pharmaceuticals have been approved for the market by the U.S. Food and Drug Administration, according to the federal Agriculture Department. Last year, only about 45 acres of the crops were grown nationwide, under strict federal guidelines.

Menu

Home

Subscriptions

News Archive

News Reviews

Videos

Articles

GM Myth Makers

GM Reports

GM Myths

GM Quotes

Non-GM Successes

Contacts

Contact Us

About

Facebook

Twitter

Donations

Content 1999 - 2023 GMWatch.
Web Development By SCS Web Design